Literature DB >> 15215200

Influence of relaxin on the neurally induced relaxant responses of the mouse gastric fundus.

Maria Caterina Baccari1, Daniele Bani, Mario Bigazzi, Franco Calamai.   

Abstract

The peptide hormone relaxin has been reported to depress the amplitude of contractile responses in the mouse gastric fundus by upregulating nitric oxide (NO) biosynthesis at the neural level. In the present study, we investigated whether relaxin also influenced nonadrenergic, noncholinergic (NANC) gastric relaxant responses in mice. Female mice in proestrus or estrus were treated for 18 h with relaxin (1 microg s.c.) or vehicle (controls). Mechanical responses of gastric fundal strips were recorded via force-displacement transducers. In carbachol precontracted strips from control mice and in the presence of guanethidine, electrical field stimulation (EFS) elicited fast relaxant responses that may be followed by a sustained relaxation. All relaxant responses were abolished by tetrodotoxin. Relaxin increased the amplitude of the EFS-induced fast relaxation without affecting either the sustained one or the direct smooth muscle response to papaverine. In the presence of the NO synthesis inhibitor L-N(G)-nitro arginine (L-NNA), that abolished the EFS-induced fast relaxation without influencing the sustained one, relaxin was ineffective. In strips from relaxin-pretreated mice, EFS-induced fast relaxations were enhanced in amplitude with respect to the controls, while sustained ones as well as direct smooth muscle responses to papaverine were not changed. Further addition of relaxin to the bath medium did not influence neurally induced fast relaxant responses, whereas L-NNA did. In conclusion, in the mouse gastric fundus, relaxin enhances the neurally induced nitrergic relaxant responses acting at the neural level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215200     DOI: 10.1095/biolreprod.104.029579

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  4 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

2.  Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.

Authors:  K P Patel; A S Giraud; C S Samuel; S G Royce
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

3.  Relaxin influences ileal muscular activity through a dual signaling pathway in mice.

Authors:  Eglantina Idrizaj; Rachele Garella; Fabio Francini; Roberta Squecco; Maria Caterina Baccari
Journal:  World J Gastroenterol       Date:  2018-02-28       Impact factor: 5.742

4.  Tissue-specific relaxin-2 is differentially associated with the presence/size of an arterial aneurysm and the severity of atherosclerotic disease in humans.

Authors:  Konstantinos Papoutsis; Alkistis Kapelouzou; Georgios Georgiopoulos; Christos Kontogiannis; Christos Kourek; Konstantinos S Mylonas; Nikolaos Patelis; Dennis V Cokkinos; Ioannis Karavokyros; Sotirios Georgopoulos
Journal:  Acta Pharmacol Sin       Date:  2020-02-05       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.